Ultralife Co. (NASDAQ:ULBI) Director Janie Goddard Buys 1,500 Shares

Ultralife Co. (NASDAQ:ULBIGet Free Report) Director Janie Goddard purchased 1,500 shares of the firm’s stock in a transaction on Monday, September 11th. The shares were purchased at an average price of $10.36 per share, for a total transaction of $15,540.00. Following the completion of the purchase, the director now directly owns 1,500 shares of the company’s stock, valued at $15,540. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Ultralife Stock Down 1.2 %

Shares of NASDAQ ULBI traded down $0.12 during mid-day trading on Tuesday, hitting $10.16. The company had a trading volume of 177,019 shares, compared to its average volume of 99,090. The company has a market capitalization of $164.09 million, a PE ratio of 60.47 and a beta of 1.37. The company has a debt-to-equity ratio of 0.19, a current ratio of 3.01 and a quick ratio of 1.43. Ultralife Co. has a 1-year low of $3.67 and a 1-year high of $10.75. The business’s 50-day simple moving average is $7.57 and its 200 day simple moving average is $5.42.

Ultralife (NASDAQ:ULBIGet Free Report) last announced its quarterly earnings data on Thursday, July 27th. The technology company reported $0.29 earnings per share (EPS) for the quarter. The business had revenue of $42.69 million for the quarter. Ultralife had a return on equity of 3.92% and a net margin of 1.76%.

Institutional Trading of Ultralife

Hedge funds have recently modified their holdings of the stock. Shikiar Asset Management Inc. acquired a new stake in shares of Ultralife in the first quarter valued at $40,000. Northern Trust Corp raised its stake in Ultralife by 7.2% in the second quarter. Northern Trust Corp now owns 23,590 shares of the technology company’s stock valued at $114,000 after buying an additional 1,592 shares in the last quarter. EA Series Trust acquired a new stake in Ultralife in the second quarter valued at $119,000. Millennium Management LLC acquired a new stake in Ultralife in the fourth quarter valued at $99,000. Finally, Susquehanna International Group LLP acquired a new stake in Ultralife in the fourth quarter valued at $145,000. 25.84% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have commented on the company. StockNews.com assumed coverage on Ultralife in a research note on Wednesday, August 23rd. They set a “strong-buy” rating on the stock. Benchmark restated a “buy” rating and set a $12.00 price target on shares of Ultralife in a research note on Tuesday, August 8th. Finally, TheStreet upgraded Ultralife from a “d+” rating to a “c-” rating in a research note on Wednesday, July 12th.

Read Our Latest Stock Analysis on ULBI

About Ultralife

(Get Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Featured Stories

Insider Buying and Selling by Quarter for Ultralife (NASDAQ:ULBI)

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.